Sistema intravítreo bioerudivel de liberación prolongada de microesferas de triamcinolona (RETAAC). Comunicación preliminar de su utilidad potencial para el tratamiento del edema macular diabético

Autoria(s): Cardillo, J. A.; Souza-Filho, A. A.; Oliveira, Anselmo Gomes de
Contribuinte(s)

Universidade Estadual Paulista (UNESP)
Data(s)

27/05/2014

27/05/2014

01/12/2006
Formato

675-682
Identificador

http://dx.doi.org/10.4321/S0365-66912006001200002

Archivos de la Sociedad Espanola de Oftalmologia, v. 81, n. 12, p. 675-682, 2006.

0365-6691

http://hdl.handle.net/11449/69315

10.4321/S0365-66912006001200002

S0365-66912006001200002

2-s2.0-34248214266

S0365-66912006001200002.pdf
Idioma(s)

spa

eng
Relação

Archivos de la Sociedad Espanola de Oftalmologia
Direitos

openAccess
Palavras-Chave #antiinflammatory agent #glycolic acid derivative #microsphere #poly (lactic co glycolic acid) #poly (lactic-co-glycolic acid) #triamcinolone acetonide #unclassified drug #delayed release formulation #diabetes mellitus #drug screening #editorial #human #injection #pilot study #retina macula cystoid edema #vitreous body #Anti-Inflammatory Agents #Delayed-Action Preparations #Diabetes Complications #Drug Evaluation #Glycolates #Humans #Injections #Macular Edema, Cystoid #Microspheres #Pilot Projects #Triamcinolone Acetonide #Vitreous Body
Tipo

info:eu-repo/semantics/other
Acesso ao item digital